SUICIDE ATTEMPTS BY MEDICATION IN BRAZIL BETWEEN 2015 AND 2023: AN EPIDEMIOLOGICAL ANALYSIS BASED ON SINAN DATA
DOI:
https://doi.org/10.51891/rease.v12i11.32564Keywords:
Suicide attempt, Poisoning, Pharmaceutical servicesAbstract
Suicide attempts by medication are a growing public health problem in Brazil. This study analyzed the epidemiological profile and temporal evolution of notifications of suicide attempts by medication poisoning recorded in the Notifiable Diseases Information System (SINAN) between 2015 and 2023. This is a descriptive, population-based, quantitative study using secondary data from DATASUS/TabNet, analyzed through absolute and relative frequencies, percentage change and case fatality. A total of 516,259 notifications were identified, with an increase of 323.3% over the period and a 26.2% drop in 2020. Women (77.7%), adults aged 20 to 39 years (49.6%) and residents of the Southeast region (51.5%) predominated. Most cases progressed to cure without sequelae (79.8%), and deaths from poisoning accounted for 0.55% of notifications. Case fatality fell from 0.88% to 0.46% and the proportion of unknown outcomes rose from 11.5% to 17.4%, indicating that part of the growth reflects the expansion of surveillance. The condition has national magnitude and an upward trajectory, and pharmaceutical care holds a strategic position in prevention.
Downloads
Downloads
Published
Issue
Section
Categories
License
Atribuição CC BY